Celldex Therapeutics, Inc.

Connor, Clark & Lunn Investment Management Ltd. CLDX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

118,205

Value ($000)

3,210

Weight

0.0%

2020 Q3 - 2025 Q4 (11 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	3,210	0.0%	118,205	12/31/2025
2024 Q1	5/9/2024	342	0.0%	8,158	3/31/2024
2023 Q4	2/9/2024	1,132	0.0%	28,538	12/31/2023
2023 Q3	11/13/2023	500	0.0%	18,155	9/30/2023
2023 Q1	5/10/2023	1,534	0.0%	42,636	3/31/2023
2022 Q4	2/10/2023	2,581	0.0%	57,910	12/31/2022
2022 Q3	11/10/2022	2,267	0.0%	80,650	9/30/2022
2021 Q3	11/12/2021	654	0.0%	12,117	9/30/2021
2021 Q2	8/12/2021	486	0.0%	14,533	6/30/2021
2020 Q4	2/16/2021	654	0.0%	37,346	12/31/2020
2020 Q3	11/12/2020	765	0.0%	51,579	9/30/2020